Gender Reassignment Surgery in Human Immunodeficiency Virus-Positive Patients: A Report of Two Cases |
Kim, Seok-Kwun
(Department of Plastic and Reconstructive Surgery, Dong-A University School of Medicine)
Choi, Ji-An (Department of Plastic and Reconstructive Surgery, Dong-A University School of Medicine) Kim, Myung-Hoon (Department of Plastic and Reconstructive Surgery, Dong-A University School of Medicine) Kim, Min-Su (Department of Plastic and Reconstructive Surgery, Dong-A University School of Medicine) Lee, Keun-Cheol (Department of Plastic and Reconstructive Surgery, Dong-A University School of Medicine) |
1 | Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. Aids 2009;23:1397-404. DOI |
2 | Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60. DOI |
3 | Lane HC, Masur H, Edgar LC, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309:453-8. DOI |
4 | Leone S, Gregis G, Quinzan G, et al. Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort. Infection 2011;39:13-20. DOI |
5 | Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399-406. DOI |
6 | Schnittman SM, Greenhouse JJ, Psallidopoulos MC, et al. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990;113:438-43. DOI |
7 | Seltzer DG, McAuliffe J, Campbell DR, et al. AIDS in the hand patient: the team approach. Hand Clin 1991;7:433-45. |
8 | Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS (London, England) 2008;22:2179-85. DOI |
9 | Mayer KH, Mimiaga MJ, Gelman M, et al. Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence. J Acquir Immune Defic Syndr 2012;59:354-9. DOI |
10 | Henderson DK, Fahey BJ, Willy M, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation. Ann Intern Med 1990;113:740-6. DOI |
11 | Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-80. DOI |
12 | Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure: Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997; 337:1485-90. DOI |
13 | Panlilio AL, Cardo DM, Grohskopf LA, et al. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for post-exposure prophylaxis. MMWR Recomm Rep 2005;54:1-17. |
14 | Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000;74:9771-5. DOI |
![]() |